Danatlas participated in the "2024 China-UK Biomedicine Exchange and Discussion Forum"

June 27, Danatlas was invited to attend the "2024 Sino-British Biopharmaceutical Exchange and Discussion Forum" held in Beijing Yizhuang.

Li Hongmei, Vice President of R&D, attended the forum as a representative of key new drug R&D enterprises in the development zone. The forum, themed "Cooperative Dialogue, Win-Win Development," was jointly held by the Beijing Economic Development Zone Management Committee and the 48 Group Club of the United Kingdom. Leaders from various levels of government units, including the National Health Commission, the China Council for the Promotion of International Trade, and the Chinese Academy of Sciences, as well as experts, scholars, and entrepreneurs from the biopharmaceutical fields of both China and the UK, attended the forum. The aim was to focus on the industrial advantages of both countries in the pharmaceutical field, increase investment attraction and technological cooperation in the pharmaceutical field, and further build a platform for Sino-British government-enterprise exchange and cooperation.